Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
NeuBase Therapeutics
(NBSE) Q4 2022
Earnings
NBSE
Feb 14
Confirmed
May 2022
Aug 2022
Dec 2022
Q4 2022
-0.3
-0.24
-0.19
-0.13
Details
Expected EPS
-0.2
Actual EPS
-0.13
Surprise EPS
0.07
Surprise Percent
+35%
Description
NeuBase Therapeutics (NBSE) has reported earnings of -0.13 per share for Q4 2022.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login